Keyphrases
Body Mass Index
100%
Intervention Group
100%
Obesity in Adolescents
100%
Obesity in children
100%
Obesity Treatment
100%
Drug Intervention
100%
Metformin
66%
Orlistat
66%
Behavior Change
33%
Obese children
33%
Sibutramine
33%
Diet Exercise
33%
Fluoxetine
33%
Child or Adolescent
33%
Placebo
16%
Treatment Group
16%
Health Problems
16%
Weight Measurement
16%
Height Measurement
16%
Health-related Quality of Life
16%
Participant Views
16%
Intervention Effect
16%
Socio-economic Impact
16%
Physical Functioning
16%
Heart Rate
16%
What Works
16%
Number of Participants
16%
Later Life
16%
Body Fat
16%
Dropout
16%
Suicide
16%
Mental Functions
16%
Reported Health
16%
Dietary Counseling
16%
Length of Follow-up
16%
Loose Stools
16%
Exenatide
16%
Diarrhea
16%
Gallstones
16%
Lifestyle Modification
16%
Highest Weight
16%
Constipation
16%
Social Functioning
16%
High Blood Pressure
16%
Topiramate
16%
Weight Change
16%
Tachycardia
16%
Certainty of Evidence
16%
Dry Mouth
16%
Emotional Functioning
16%
Randomized Controlled Study
16%
Drug Treatment
16%
Childhood Body Mass Index
16%
Obese Adolescents
16%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Tetrahydrolipstatin
100%
Metformin
100%
Obesity
75%
Disease
50%
Sibutramine
50%
Fluoxetine
50%
Placebo
25%
Topiramate
25%
Tachycardia
25%
Clinical Study
25%
Loose Feces
25%
Gallstone
25%
Xerostomia
25%
Pharmacotherapy
25%
Constipation
25%
Hypertension
25%
Diarrhea
25%
Exendin 4
25%
Medicine and Dentistry
Adolescence
100%
Body Mass Index
77%
Side Effect
44%
Glycon
44%
Orlistat
44%
Obesity
33%
Disease
22%
Fluoxetine
22%
Sibutramine
22%
Quality of Life
11%
Social Interaction
11%
Gut
11%
Outcome Assessment
11%
Placebo
11%
Drug Therapy
11%
Clinical Study
11%
Exenatide
11%
Xerostomia
11%
Body Weight Change
11%
Counseling
11%
Diarrhea
11%
Body Fat
11%
Hypertension
11%
Constipation
11%
Topiramate
11%
Loose Feces
11%
Tachyarrhythmia
11%
Medicine
11%
Gallstone
11%
Lifestyle Modification
11%
Nursing and Health Professions
Adolescent
100%
Body Mass
77%
Metformin
44%
Tetrahydrolipstatin
44%
Side Effect
44%
Obesity
33%
Disease
22%
Fluoxetine
22%
Sibutramine
22%
Quality of Life
11%
Drug Therapy
11%
Placebo
11%
Lifestyle Modification
11%
Hypertension
11%
Body Fat
11%
Body Weight Change
11%
Diarrhea
11%
Exendin 4
11%
Constipation
11%
Outcome Assessment
11%
Gallstone
11%
Topiramate
11%
Loose Feces
11%
Tachycardia
11%
Xerostomia
11%
Counseling
11%
Psychology
Adolescence
100%
Body Mass Index
77%
Metformin
44%
Quality of Life
11%
Blood Pressure
11%
Social Functioning
11%